Ofloxacin, as per the Indian Pharmacopoeia (IP), is a broad-spectrum fluoroquinolone antibiotic known for its efficacy against a wide range of bacterial infections. It acts by inhibiting bacterial DNA gyrase, thereby disrupting DNA replication and transcription, leading to bacterial cell death.